1. Home
  2. DXR vs SCWO Comparison

DXR vs SCWO Comparison

Compare DXR & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXR
  • SCWO
  • Stock Information
  • Founded
  • DXR 1970
  • SCWO 2021
  • Country
  • DXR United States
  • SCWO United States
  • Employees
  • DXR N/A
  • SCWO N/A
  • Industry
  • DXR Medical/Dental Instruments
  • SCWO Environmental Services
  • Sector
  • DXR Health Care
  • SCWO Utilities
  • Exchange
  • DXR Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • DXR 46.9M
  • SCWO 49.2M
  • IPO Year
  • DXR N/A
  • SCWO N/A
  • Fundamental
  • Price
  • DXR $13.50
  • SCWO $0.37
  • Analyst Decision
  • DXR Strong Buy
  • SCWO
  • Analyst Count
  • DXR 1
  • SCWO 0
  • Target Price
  • DXR $25.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • DXR 5.1K
  • SCWO 813.3K
  • Earning Date
  • DXR 01-01-0001
  • SCWO 11-12-2025
  • Dividend Yield
  • DXR N/A
  • SCWO N/A
  • EPS Growth
  • DXR 3.46
  • SCWO N/A
  • EPS
  • DXR 0.36
  • SCWO N/A
  • Revenue
  • DXR $66,306.00
  • SCWO $1,231,413.00
  • Revenue This Year
  • DXR N/A
  • SCWO $5,945.19
  • Revenue Next Year
  • DXR N/A
  • SCWO $106.82
  • P/E Ratio
  • DXR $38.30
  • SCWO N/A
  • Revenue Growth
  • DXR N/A
  • SCWO 403.17
  • 52 Week Low
  • DXR $6.55
  • SCWO $0.16
  • 52 Week High
  • DXR $14.00
  • SCWO $1.95
  • Technical
  • Relative Strength Index (RSI)
  • DXR 66.65
  • SCWO 65.88
  • Support Level
  • DXR $13.39
  • SCWO $0.28
  • Resistance Level
  • DXR $14.00
  • SCWO $0.32
  • Average True Range (ATR)
  • DXR 0.50
  • SCWO 0.03
  • MACD
  • DXR 0.13
  • SCWO 0.00
  • Stochastic Oscillator
  • DXR 80.93
  • SCWO 83.14

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: